Raphaëlle Lambion

Raphaëlle Lambion is currently a Global Regulatory Affairs CMC professional at Merck Group, focusing on Large Molecules R&D and Small Molecules Lifecycle. With a profound background in regulatory science, they have held significant roles in companies such as Celgene, Ferring Pharmaceuticals, and Alexion Pharmaceuticals. Prior to this, they managed quality assurance as a Quality Manager at Molnlycke Health Care and gained valuable experience at Baxter BioScience in Global Regulatory Affairs. Additionally, Raphaëlle served as a scientific responsible and lecturer at the University of Neuchâtel, demonstrating a commitment to both practical and educational aspects of their field. They hold a Master of Science degree from the University of Liège and a CEPAC from the Solvay Brussels School of Economics and Management.